However, this study uniquely demonstrates that dual MCT1 and MCT4 inhibition with syrosingopine was more potent in primary CD138 + MM cells derived from patients with elevated serum LDH levels than those without elevated serum LDH levels. Here, SDC1 is linked to Miyoshi myopathy.